# TASK ORDER 01 COCAINE INTERACTION SAFETY STUDIES IN RATS. TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS IDIQ. ORDERING PERIOD: 09/12/2023 - 09/11/2024. NIDA REF. NO. N01DA-23-8939

> **NIH NIH N01** · SRI INTERNATIONAL · 2023 · $571,190

## Abstract

The overall objective of this contract is to provide NIDA with safety pharmacology & toxicology testing services for novel compounds being developed for the treatment of substance use disorders. SRI will perform pharmacology, safety, & toxicity studies to support Investigational New Drug and New Drug Application submissions to the U.S. FDA on compounds identified by the NIDA COR for inclusion in this program. The exact details of the work to be conducted for individual compounds or tasks will be determined on a case-by-case basis, as directed by the NIDA COR.

## Key facts

- **NIH application ID:** 10947939
- **Project number:** 75N95023D00023-0-759502300001-1
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** Maria Arolfo
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $571,190
- **Award type:** —
- **Project period:** 2023-09-12 → 2024-09-11

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10947939

## Citation

> US National Institutes of Health, RePORTER application 10947939, TASK ORDER 01 COCAINE INTERACTION SAFETY STUDIES IN RATS. TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS IDIQ. ORDERING PERIOD: 09/12/2023 - 09/11/2024. NIDA REF. NO. N01DA-23-8939 (75N95023D00023-0-759502300001-1). Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/grant/nih/10947939. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*